Genesis Research & Development has given more details on a plan to raise cash from shareholders.
The biotechnology company wants to raise $1 million to fund its operations and is offering extra shares at 6 cents, up to $5000 worth.
Genesis Research & Development is also in talks to secure a major investor to develop its gene silencing technology.
